Distinguishing T1D vs. T2D in Childhood: a case report for discussion

Similar documents
Type 2 Diabetes in Adolescents

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Type 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER

Diabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.

Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus. History - 1

Laboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011

DIABETES MELLITUS. IAP UG Teaching slides

51 year old woman with hyperglycemia. August 9, 2012 Katie Stanley, MD

V. N. Karazin Kharkiv National University Department of internal medicine Golubkina E.O., ass. of prof., Shanina I. V., ass. of prof.

Atypical and Ketosis Prone Diabetes. Ashok Balasubramanyam, MD Baylor College of Medicine Houston, Texas

Diabetes Mellitus (DM) - Dr Hiren Patt

Case- history. Lab results

Diabetes Mellitus in the Pediatric Patient

Addressing Addressing Challenges in Type 2 Challenges in Type 2 Diabetes Diabetes Speaker:

AUGUST 25-27, 2017 UPDATE & BOARD REVIEW. acofp INTENSIVE. Diabetes Review. Colleen Cagno, MD INNOVATIVE COMPREHENSIVE HANDS-ON

Blood Pressure Measurement (children> 3 yrs)

Type 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I

Leslie K Scott PhD, PNP-BC, CDE University of Kentucky

Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014

Diabetes Update 2018: Pathogenesis of Diabetes

Type 1 Diabetes in Children and Adolescents

Childhood Obesity and Type II Diabetes: A Rising Epidemic

Helpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center

Clinical Practice Guidelines for Diabetes Management

Clinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013

Incidence trends of type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children

Management of Pregestational and Gestational Diabetes Mellitus

Vishwanath Pattan Endocrinology Wyoming Medical Center

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM

Course Objectives. Diabetes Fundamentals Series Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services

Study Code: Date: 27 July 2007

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Standards of Medical Care in Diabetes Adult/Pediatric Inpatient/Ambulatory Clinical Practice Guideline

Adolescent Obesity GOALS BODY MASS INDEX (BMI)

Metabolic Syndrome Across the Life Cycle - Adolescent. Joy Friedman MD

DOWNLOAD OR READ : TYPE I JUVENILE DIABETES PDF EBOOK EPUB MOBI

CE on SUNDAY Newark, NJ October 18, 2009

Developmental origins of type 2 diabetes in children. DCPNS April 16, 1010

Non-type 1 diabetes mellitus in Canadian children

Living Well with Diabetes

Disclosures. Diabetes and Obesity Care in Vulnerable Populations. Objectives. New diabetes cases, at long last, begin to fall 3/12/2016

PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)

DISCLOSURES: 8/27/18 USE OF A SHARED MEDICAL APPOINTMENT FOR PEDIATRIC OBESITY

Case Report Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

The Changing Face of Diabetes in Youth: Lessons Learned from Studies of Type 2

Diabetes Related Disclosures

Non-insulin treatment in Type 1 DM Sang Yong Kim

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

Clinical Practice Guideline: Care of Children & Adolescents with Type I Diabetes mellitus

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It

Early Diagnosis of T1D Through An3body Screening

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program

5/12/2011. Recognize the major types of diabetes: Type 2, Type 1A, Type 1B, MODY, LADA, Pancreatic diabetes, drug-induced DM

CIT-06 Eligibility Questionnaire

The National Diabetes Prevention Program in Washington State March 2012

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

George Ford MD MS Assistant Professor Pediatric Endocrinology ETSU and Niswonger Children s Hospital

Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes

What is diabetes? Community Health Education Lecture Series November 18, Cara L. Kilroy, ANP-BC

Monthly WellPATH Spotlight November 2016: Diabetes

The quality of clinical practice guidelines for management of pediatric type 2 diabetes mellitus: a systematic review using the AGREE II instrument

Prediabetes & Type 2 Diabetes Prevention. Jacob M. Haus, PHD

Clinical practice guidelines in management of type 1 diabetic patients

American Academy of Insurance Medicine

Population Screening for T1D and Celiac Disease

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

MANAGEMENT OF TYPE 1 DIABETES MELLITUS

WELL-WOMAN EXAM REVEALS RISK. Katie Jones, MPH, CHES Iowa Department of Public Health Erin Hinderaker, MS, RD, LD Des Moines University

Diabetes Case Study: Co-morbidity of Nonadherence

RELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES. Yuan Gu

What s new in diabetes care? Connect and Learn April 13, 2018 Tess Montada-Atin NP-Adult, CDE

Type I diabetes mellitus. Dr Laurence Lacroix

7/8/2016. Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine

Diagnosis of Diabetes

It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children

Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates

Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18

67 year-old Male with Flu-like Symptoms. Jess Hwang 12/6/12

NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes

A Study on the Presence of Islets Cell Autoantibodies in Non- Insulin Requiring Young Diabetic Patients

Type 1 and Type 2 Diabetes among Youths in Jordan: Incidence and Trends for the period ( ) Abstract Acknowledgement 1.

associated with serious complications, but reduce occurrences with preventive measures

DIABETES OVERVIEW WHAT IS DIABETES?

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019

Center for healthy weight and Nutrition. Primary Care Pocket Guide to. Pediatric Obesity Management

Diabetes Mellitus Definition

Diabetes mellitus is a complex of syndromes characterized metabolically by hyperglycemia and altered glucose metabolism, and associated

GLUCOSE CONTROL IN THE SURGICAL SETTING

Am I at Risk for Type 2 Diabetes?

Diabetes in Pregnancy

Pediatric Type 2 Diabetes: What is the big deal? Jay Shubrook DO FACOFP Professor, Diabetologist Touro University CA, COM

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland

Prediction and Prevention of Type 1 Diabetes. How far to go?

Peripartum and Postpartum Management of Diabetes

Screening and Diagnosis of Diabetes Mellitus in Taiwan

Prevention and Management of Diabetes in Pregnancy

Transcription:

Distinguishing T1D vs. T2D in Childhood: a case report for discussion Alba Morales, MD Associate Professor of Pediatrics Division of Pediatric Endocrinology and Diabetes

Disclosure I have no financial disclosures to report.

OBJECTIVES 1. List 3 clinical and biochemical characteristics typically found in children with new onset type 1 diabetes mellitus. 2. Recognize the difficulty in distinguishing between type 1 and type 2 diabetes mellitus in youth given the high prevalence of obesity in this population. 3. Enumerate 3 clinical and biochemical characteristics typically found in youth with new onset type 2 diabetes mellitus.

Seniors 1975

Seniors 2015

Example Case Dee - Previously healthy 9 year old female with 4-6 weeks of increased thirst, urination, fatigue. Mother has Insulin-dependent diabetes so she checked girl s BG with her home meter (245 mg/dl) Taken to PCP where: Weight: 130 lbs. Height: 5 ft B/P: 110/65 HR: 104/min POC BG: 223 mg/dl (fasting) Urine: 1000 glucose, small ketones

CAN WE SAY: A. She has type 1 diabetes? B. She has type 2 diabetes? C. She has diabetes?

What can we say for sure? This girl has new onset diabetes Type? Most appropriate initial management? Referral? Education?

More information Patient complains of dysuria, perineal pruritus. Has history of eczema, seasonal allergies Father takes pills for his blood sugar, mother takes insulin Several 2 nd degree and more distant relatives with Type 2 diabetes in family Physical exam: No acute distress, well hydrated, obese and tall Normal otherwise except for very mild darkening/ thickening of skin around neck She is pre-pubertal

What other information? Ethnicity Caucasian, Irish- English descent Weight loss? Has lost 5-7 lbs in last 2 weeks A1c= 9.5% (information not available until day after clinic visit) Maternal age at diagnosis and diabetes medications taken Mom was 10 years old at diagnosis, uses an insulin pump for her diabetes care

Our case: PCP diagnosed Dee with Type 2 diabetes and started her on Metformin 500 mg by mouth twice daily Asked mom to check fingerstick BG 4 times per day and keep records Faxed referral to Peds ENDO at UK

Audience? AGREE DISAGREE

Childhood T2DM: disease in the child who typically is overweight or obese (BMI 85th 94th and >95th percentile for age and gender, respectively) has a strong family history of T2DM has substantial residual insulin secretory capacity at diagnosis (reflected by normal or elevated insulin and C- peptide concentrations) (?) has insidious onset of disease demonstrates insulin resistance (including clinical evidence of polycystic ovarian syndrome or acanthosis nigricans) lacks evidence for diabetic autoimmunity (negative for autoantibodies typically associated with T1DM) (?)

At UK Diabetes clinic- 2 weeks later A1c= 10.3% Glucometer data for last 2 weeks show BG range of 150-350 mg/dl Symptoms unchanged Good compliance with Metformin reported (*) Labs?

Decision-making process Type 1 Pre-pubertal 9 year old Caucasian Well defined, short course Symptoms- polys, fatigue Type 2 Obese Parent with Type 2 diabetes?? Acanthosis

Dark/ thick skin around neck Lichenification in chronic eczema Acanthosis nigricans

Initial management Insulin Used in all ages A1c > 9% Useful in all types of diabetes Clear per kg dosing guidelines INJECTIONS/ NEEDLES!! Hypoglycemia/ education Metformin FDA approved for age 11+ Tablets Few mild side effects Lowers A1c only by 1.5-2% if used correctly Contraindicated in Type 1 diabetes

Work-up C-peptide GAD-A antibody (Glutamic acid decarboxylase) ICA antibody (Islet cell cytoplasmic) Zn T8 (Zinc transporter 8 protein) IAA (Insulin autoantibodies) IA-2 (Insulinoma 2-associated antibodies)

Dee- Results GAD + IAA + Zn Tr8 + C-peptide= 0.3 (0.8-5.3 ng/ml)

Type 2 Diabetes in Youth Insulin resistance + impaired β-cell function =HYPERGLYCEMIA Genetic predisposition Mother with GDM Fetal programming - SGA Metabolic memory OBESITY ACANTHOSIS NIGRICANS ETHNICITY Hypertension and hyperlipidemia NAFLD

Type 1 vs. Type 2 11% overweight (up to 22%) Shorter, well defined course DKA -up to 40% 5% with family history T1DM > 80% overweightacanthosis Insidious course, poorly defined ¼-⅓ with mild ketonuria Almost 100% with 1 st or 2 nd degree affected relative

Differences Type 1 Low c-peptide Caucasian race Higher incidence of other autoimmune disorders Presence of beta-cell autoimmunity markers Type 2 Normal, high c-peptide/ insulin levels Ethnic minority youth Absent autoimmunity markers

217 consecutive kids with new onset diabetes at KCH (2015-17) Characteristic Type 1 diabetes Type 2 diabetes Number 201 (93%) 16 (7%) BMI range 13-41 25-59 Age ranges 11 months- 17 years Most frequent age at diagnosis = 12 y 2 nd most frequent age= 7 y 11 y- 17 y (average age 15) Most frequent age at diagnosis= 16 y

30% of American youth (10-18) with new onset diabetes have T2DM: 46.1% of Hispanic youth 57.8% of non-hispanic blacks 69.7% of Asian/ Pacific Islanders 86.2% in Native Americans 14.9% in non-hispanic whites (3 out of 20 new onset kids) Dabelea D, Bell RA, D Agostino Jr RB, Imperatore G, Johansen JM,Linder B, Liu LL, Loots B, Marcovina S, Mayer-Davis EJ, Pettitt DJ,Waitzfelder B; SEARCH for Diabetes in Youth Study Group 2007. Incidence of diabetes in youth in the United States. JAMA 297:2716 2724

Consider use of Metformin Obese child with new diabetes Pubertal (post menarche) Ethnicity (AA, Latino, Native American) Evidence of insulin resistance (acanthosis, PCOS) Family history (mom or dad or both T2DM) Incidental finding, asymptomatic School physical BG check by family member Strong suspicion for T2DM Small or < urine ketones Normal/ high insulin or c-peptide level HbA1c < 9%

Consider use of Insulin as first choice Obese child with new diabetes Pubertal (post menarche) Ethnicity (AA, Latino, Native American) Evidence of insulin resistance (acanthosis, PCOS) Family history (mom or dad or both T2DM) Symptomatic School physical BG check by family member Strong suspicion for T2DM Moderate or >urine ketones HbA1c > 9%

Always Insulin as first choice Obese child with diabetes Pre-pubertal Caucasian No signs of insulin resistance No parent with T2DM Polys and/ or weight loss present Tested for diabetes due to symptoms Strong suspicion of T1DM Normal, low C- peptide Positive pancreatic autoantibodies

References Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline. J Clin Endocrinol Metab 96: 159 167, 2011 Management of Type 2 Diabetes Mellitus in Children and Adolescents http://pediatrics.aappublications.org/content/131/2/e648.full.html Dabelea D, Bell RA, D Agostino Jr RB, Imperatore G, Johansen JM,Linder B, Liu LL, Loots B, Marcovina S, Mayer-Davis EJ, Pettitt DJ,Waitzfelder B; SEARCH for Diabetes in Youth Study Group 2007. Incidence of diabetes in youth in the United States. JAMA 297:2716 2724 Alba Morales Pozzo, M.D. Email: amo278@uky.edu